CE25-149 - Rigorous Evaluation of Community-Delivered Short- and Long-Acting Buprenorphine to People who Experience Homelessness or Live at Permanent Supportive Housing Sites
About This Grant
Project Abstract The intersection of the overdose and housing crises has prompted unprecedented mortality among our nation’s most vulnerable residents – people who experience homelessness (PEH). Multilevel barriers to care often obstruct this population’s access to medications for opioid use disorder (MOUD) -- a secondary overdose prevention strategy that halves the risk of overdose and improves other health outcomes. To eliminate the barriers associated with traveling to healthcare facilities for MOUD appointments and prescription refills, Public Health – Seattle and King County (PHSKC) will pilot a new MOUD service delivery model. Starting in 2025, buprenorphine prescriptions ordered during street medicine or telemedicine encounters at participating encampments, shelters and permanent supportive housing (PSH) sites will be filled at the Downtown Public Health Pharmacy and transported by a nurse-led care team, who will disburse short-acting sublingual and administer long-acting injectable buprenorphine directly to patients in the field. This study will employ a Type 2 Implementation-Effectiveness Hybrid design to evaluate this pilot program. Using quasi-experimental methods, we will evaluate the effect of community-delivered buprenorphine on (i) the risk of overdose in a propensity score matched patient cohort and (ii) occurrence of overdose at PSH sites, assessed via interrupted time series. Guided by the RE-AIM Implementation Science Framework, we will measure patient-level and systems-level implementation outcomes. This rigorous evaluation will generate real-world evidence for a (i) community-based MOUD delivery model and (ii) long-acting injectable buprenorphine. Findings from this evaluation will inform how these innovations can be adapted and brought to scale both locally and in other jurisdictions that grapple with the syndemic overdose and housing crises.
Grant Summary
CE25-149 - Rigorous Evaluation of Community-Delivered Short- and Long-Acting Buprenorphine to People who Experience Homelessness or Live at Permanent Supportive Housing Sites is a NCIPC - National Center for Injury Prevention and Control grant providing up to $350K for university, nonprofit, healthcare org. Applications are due 2028-09-29 (open). Check eligibility and apply with FindGrants.
Not quite the right fit?
Search 9,000+ open grants, or get matches ranked for your organization — free.
Focus Areas
Eligibility
How to Apply
Up to $350K
2028-09-29
- 1Confirm your organization is eligible for CE25-149 - Rigorous Evaluation of Community-Delivered Short- and Long-Acting Buprenorphine to People who Experience Homelessness or Live at Permanent Supportive Housing Sites from NCIPC - National Center for Injury Prevention and Control, checking organization type, location, and any population or project requirements.
- 2Gather the required documents and information, including your organization details, project plan, and budget figures.
- 3Draft your application narrative and budget addressing the funder's priorities and review criteria. FindGrants can draft each section for you to review and edit.
- 4Review every section against the requirements checklist, then export a submission-ready application pack and submit it to NCIPC - National Center for Injury Prevention and Control before the deadline.
Don't want to draft it yourself?
We'll draft the complete application against NCIPC - National Center for Injury Prevention and Control's requirements, run a quality review, and email you a submission-ready PDF plus an editable Word doc within 5 business days. Most orders deliver in 24-48 hours. Flat $399, any grant size.
AI Requirement Analysis
Detailed requirements not yet analyzed
Have the NOFO? Paste it below for AI-powered requirement analysis.
CE25-149 - Rigorous Evaluation of Community-Delivered Short- and Long-Acting Buprenorphine to People who Experience Homelessness or Live at Permanent Supportive Housing Sites: Frequently Asked Questions
Who is eligible for the CE25-149 - Rigorous Evaluation of Community-Delivered Short- and Long-Acting Buprenorphine to People who Experience Homelessness or Live at Permanent Supportive Housing Sites?
CE25-149 - Rigorous Evaluation of Community-Delivered Short- and Long-Acting Buprenorphine to People who Experience Homelessness or Live at Permanent Supportive Housing Sites is offered by NCIPC - National Center for Injury Prevention and Control and is generally open to university, nonprofit, healthcare org. It is open to organizations nationwide unless the funder specifies otherwise. Review the specific eligibility terms before applying, since funders set their own requirements around organization type, location, and the population or project being served.
How much funding does the CE25-149 - Rigorous Evaluation of Community-Delivered Short- and Long-Acting Buprenorphine to People who Experience Homelessness or Live at Permanent Supportive Housing Sites provide?
CE25-149 - Rigorous Evaluation of Community-Delivered Short- and Long-Acting Buprenorphine to People who Experience Homelessness or Live at Permanent Supportive Housing Sites provides up to $350K per award from NCIPC - National Center for Injury Prevention and Control. Actual award sizes depend on the scope of your project, available program funds, and the number of applicants, so build a budget that reflects realistic, allowable costs rather than the maximum figure.
When is the CE25-149 - Rigorous Evaluation of Community-Delivered Short- and Long-Acting Buprenorphine to People who Experience Homelessness or Live at Permanent Supportive Housing Sites deadline?
Applications for CE25-149 - Rigorous Evaluation of Community-Delivered Short- and Long-Acting Buprenorphine to People who Experience Homelessness or Live at Permanent Supportive Housing Sites are due 2028-09-29 (open). Because deadlines can change, verify the date with the funder, NCIPC - National Center for Injury Prevention and Control, and give yourself enough time to prepare a complete, competitive application before the close date.
How do you apply for the CE25-149 - Rigorous Evaluation of Community-Delivered Short- and Long-Acting Buprenorphine to People who Experience Homelessness or Live at Permanent Supportive Housing Sites?
To apply for CE25-149 - Rigorous Evaluation of Community-Delivered Short- and Long-Acting Buprenorphine to People who Experience Homelessness or Live at Permanent Supportive Housing Sites, confirm your eligibility, gather the required documents, and prepare a narrative and budget that address the funder's priorities. FindGrants guides you step by step and can draft each section, then exports a submission-ready application pack for this grant from NCIPC - National Center for Injury Prevention and Control.